Pharmion

Pharmion Corp. is a biopharmaceutical company focused on acquiring, developing, and commercializing innovative products for the treatment of patients with hematological and oncological conditions. Pharmion Corp. has multiple products on the market, including Vidaza(R), the world's first approved epigenetic anticancer drug, a DNA demethylating agent.